Anthem (NYSE: ANTM) is one of 15 publicly-traded companies in the “Managed Health Care” industry, but how does it compare to its rivals? We will compare Anthem to similar companies based on the strength of its valuation, profitability, risk, earnings, dividends, institutional ownership and analyst recommendations.

Earnings & Valuation

This table compares Anthem and its rivals revenue, earnings per share and valuation.

Gross Revenue NetIncome Price/Earnings Ratio
Anthem $84.86 billion $2.47 billion 19.74
Anthem Competitors $50.73 billion $1.52 billion 12.06

Anthem has higher revenue and earnings than its rivals. Anthem is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Anthem and its rivals, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anthem 0 7 10 0 2.59
Anthem Competitors 81 931 1473 24 2.57

Anthem presently has a consensus target price of $197.64, indicating a potential downside of 9.45%. As a group, “Managed Health Care” companies have a potential downside of 0.58%. Given Anthem’s rivals higher probable upside, analysts plainly believe Anthem has less favorable growth aspects than its rivals.


Anthem pays an annual dividend of $2.80 per share and has a dividend yield of 1.3%. Anthem pays out 25.3% of its earnings in the form of a dividend. As a group, “Managed Health Care” companies pay a dividend yield of 0.9% and pay out 19.9% of their earnings in the form of a dividend. Anthem has increased its dividend for 2 consecutive years.


This table compares Anthem and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Anthem 3.35% 12.97% 4.97%
Anthem Competitors 1.81% 11.16% 3.57%

Volatility & Risk

Anthem has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Comparatively, Anthem’s rivals have a beta of 0.62, indicating that their average stock price is 38% less volatile than the S&P 500.

Insider & Institutional Ownership

90.0% of Anthem shares are owned by institutional investors. Comparatively, 90.6% of shares of all “Managed Health Care” companies are owned by institutional investors. 0.4% of Anthem shares are owned by insiders. Comparatively, 2.4% of shares of all “Managed Health Care” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.


Anthem beats its rivals on 10 of the 15 factors compared.

Anthem Company Profile

Anthem, Inc. is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. It also provides an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. It provides an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits and radiology benefit management.

Receive News & Ratings for Anthem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.